Disease severity in patients with visceral leishmaniasis is not altered by co-infection with intestinal parasites
نویسندگان
چکیده
Visceral leishmaniasis (VL) is a neglected tropical disease that affects the poorest communities and can cause substantial morbidity and mortality. Visceral leishmaniasis is characterized by the presence of Leishmania parasites in the spleen, liver and bone marrow, hepatosplenomegaly, pancytopenia, prolonged fever, systemic inflammation and low body mass index (BMI). The factors impacting on the severity of VL are poorly characterized. Here we performed a cross-sectional study to assess whether co-infection of VL patients with intestinal parasites influences disease severity, assessed with clinical and haematological data, inflammation, cytokine profiles and BMI. Data from VL patients was similar to VL patients co-infected with intestinal parasites, suggesting that co-infection of VL patients with intestinal parasites does not alter disease severity.
منابع مشابه
The Frequency of Intestinal Parasites in HIV Positive PatientsAdmitted To the Disease Consultation Center in Kermanshah Province.
Abstract Background and objectives: Acquired immunodeficiency syndrome (AIDS) is acquired by infection with human immunodeficiency virus. (HIV).Parasite caused infection is the most common problem in AIDS Patients. Sometimes unusual and opportunistic infections such as intestinal parasitic infections may cause serious gastric intestinal (GI) disorders, which can finally lead to death. The aim o...
متن کاملThe biological diagnosis of leishmaniasis in HIV-infected patients.
This review emphasises the particular difficulties encountered in confirming a suspected case of cutaneous or visceral leishmaniasis when that case is co-infected with HIV. HIV infection appears to have a more profound impact on the development of visceral leishmaniasis than on the evolution of the purely cutaneous disease. The various techniques available for immunological, parasitological and...
متن کاملPKDL and Other Dermal Lesions in HIV Co-infected Patients with Leishmaniasis: Review of Clinical Presentation in Relation to Immune Responses
BACKGROUND Co-infection of leishmaniasis and HIV is increasingly reported. The clinical presentation of leishmaniasis is determined by the host immune response to the parasite; as a consequence, this presentation will be influenced by HIV-induced immunosuppression. As leishmaniasis commonly affects the skin, increasing immunosuppression changes the clinical presentation, such as in post-kala-az...
متن کاملArginase Activity in the Blood of Patients with Visceral Leishmaniasis and HIV Infection
BACKGROUND Visceral leishmaniasis is a parasitic disease associated with high mortality. The most important foci of visceral leishmaniasis in Ethiopia are in the Northwest and are predominantly associated with high rates of HIV co-infection. Co-infection of visceral leishmaniasis patients with HIV results in higher mortality, treatment failure and relapse. We have previously shown that arginase...
متن کاملImmunity to Visceral Leishmaniasis Using Genetically Defined Live-Attenuated Parasites
Leishmaniasis is a protozoan parasitic disease endemic to the tropical and subtropical regions of the world, with three major clinical forms, self-healing cutaneous leishmaniasis (CL), mucocutaneous leishmaniasis (MCL), and visceral leishmaniasis (VL). Drug treatments are expensive and often result in the development of drug resistance. No vaccine is available against leishmaniasis. Subunit Lei...
متن کامل